Chicago Rivet & Machine (CVR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
29 Sep, 2025Executive summary
Operates in two segments: fastener (rivets, cold-formed fasteners, screw machine products) and assembly equipment (automatic rivet setting machines and parts).
Principal market is the North American automotive industry, with 35% of 2024 revenues from three major customers.
2024 saw significant recurring operating losses, negative cash flows, and reduced liquidity, raising substantial doubt about ability to continue as a going concern.
Closure of Albia, Iowa facility in 2024, with operations consolidated into Tyrone, PA.
Financial highlights
2024 net sales: $26.99M, down 14% from $31.51M in 2023.
Net loss for 2024: $5.62M ($5.81/share) vs. $4.40M ($4.56/share) in 2023.
Gross profit improved to $1.06M in 2024 from $0.60M in 2023, despite lower volumes.
Fastener segment sales fell 18% to $23.16M; assembly equipment segment sales rose 14% to $3.82M.
Fourth quarter 2024 sales declined 40% year-over-year; Q4 net loss was $3.61M.
$1.1M charge related to a customer warranty claim settlement reduced 2024 revenue.
Dividends paid in 2024 totaled $0.33/share.
Outlook and guidance
Order volume improved in Q1 2025 vs. Q4 2024 but remains below Q1 2024 levels.
Ongoing cost reductions and efficiency improvements position the company to manage uncertainty.
Focus on price adjustments, new sales opportunities, and monitoring external risks like tariffs.
Latest events from Chicago Rivet & Machine
- Shareholders will vote on director elections, executive pay, auditor ratification, and governance matters.CVR
Proxy Filing2 Dec 2025 - Returned to profitability in Q3 2025, but going concern risks persist amid industry challenges.CVR
Q3 20257 Nov 2025 - Q2 2024 returned to profit on improved margins, despite flat sales and ongoing risk from a product issue.CVR
Q2 202429 Sep 2025 - Sales fell 12.3% YoY in Q3 2024, with improved margins but a net loss of $1.45M.CVR
Q3 202429 Sep 2025 - Gross margin and net income improved despite lower sales, but liquidity risks persist.CVR
Q1 202529 Sep 2025 - Sales and margins declined in Q2 2025, raising going concern doubts despite cost actions.CVR
Q2 202529 Sep 2025